| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/13/2009 | CN101428846A Nano-hollow sphere structured amorphous zinc oxide and method for producing the same |
| 05/13/2009 | CN101428147A Process for producing composite intravenous injection formulation for treating stomach cancer |
| 05/13/2009 | CN101428146A Process for producing composite injection formulation for treating esophagus cancer |
| 05/13/2009 | CN101428145A Novel vaccine adjuvant |
| 05/13/2009 | CN101428142A Process for producing recombinant human vascular endothelial inhibitor composition sustained-release microsphere |
| 05/13/2009 | CN101428141A Recombinant human vascular endothelial inhibitor sustained-release injection oil formulation and preparation thereof |
| 05/13/2009 | CN101428140A Sustained-release incretion particle for inducing maturation of Oplegnathus fasciatus gonad and preparation method thereof |
| 05/13/2009 | CN101428069A Process for producing mulberry leaf polyphenol, microcapsule and uses thereof |
| 05/13/2009 | CN101428056A Health care formulation for improving osteoporosis of female in middle and old age and preparation method thereof |
| 05/13/2009 | CN101428035A Gemcitabine hydrochloride or gemcitabine composition |
| 05/13/2009 | CN101428032A Gentamicin gel rubber preparation |
| 05/13/2009 | CN101428020A Freeze-dried powder preparation of kuh-seng native, preparation and detection method thereof |
| 05/13/2009 | CN101428009A Insulin intranasal inhalation powder spray |
| 05/13/2009 | CN101428006A Microparticle compositions and methods for the manufacture thereof |
| 05/13/2009 | CN101428004A Green process for producing nano-hydrophilic fat medicament based on amphiphilic block polymer |
| 05/13/2009 | CN101428003A Preparation of RGDF-fatty alcohol couplet mediated adriablastina target lipid and uses as anti-tumour agents |
| 05/13/2009 | CN101427998A Astragalus polysaccharide calcium phosphate nano-paclitaxel composite injection, preparation method and application thereof |
| 05/13/2009 | CN101427996A Novel anticancer sustained-release injection |
| 05/13/2009 | CN101427995A Anticancer sustained-release agent |
| 05/13/2009 | CN101427994A Gemcitabine-containing anti-cancer medicine sustained-release injection |
| 05/13/2009 | CN101427992A Clopidogrel hydrobromate preparation and method of producing the same |
| 05/13/2009 | CN101427988A Moisture paper tissue containing hamamelidaceae plant extract liposome |
| 05/13/2009 | CN101427983A Female washing and protecting condensation with sterilizing effect and method of producing the same |
| 05/13/2009 | CN100486999C Polysaccharide pseudo-sponge |
| 05/13/2009 | CN100486646C Polyethylene glycol-phosphatidyl ethanolamine polymer or medicinal acid addition salt and application thereof in pharmacy |
| 05/13/2009 | CN100486645C Medicine composition containing cyclodextrin included taxol and its preparation process |
| 05/13/2009 | CN100486644C preparation process of superfine medicine powder with improved water solubility and its orally taken preparation |
| 05/13/2009 | CN100486643C Pharmaceutical oral dosage form comprising a non-steroidal anti-inflammatory drug, and having good palatability |
| 05/13/2009 | CN100486641C Compound bone peptide medicine composition oral preparation and preparation method therefor |
| 05/13/2009 | CN100486636C Paste for treating dental hyperesthesia and its preparing method |
| 05/13/2009 | CN100486603C Clathrate containing barrenwort total flavone cyclodextrin or cyclodextrin derivative, preparation and preparing method thereof |
| 05/13/2009 | CN100486589C Slow release antibiotics preparation of bioactive substance |
| 05/13/2009 | CN100486583C Diabetin for injection and its preparation process |
| 05/13/2009 | CN100486569C Poly olefinic taxadol self assembled precusor liposome and its preparation method |
| 05/13/2009 | CN100486560C Slow released compound anticancer injection containing blood vessel inhibitor |
| 05/12/2009 | US7531676 Bipolar; cationic head linked to a hydrophobic backbone and a hydrophilic tail; capable of self assembly to form stable complexes in aqueous solutions; use for the delivery of bioactive substances such as nucleic acids to cells in vitro and especially in vivo |
| 05/12/2009 | US7531633 Immunotherapy against infection; harvesting antibodies directed against Staphylococcus from blood of immunized subject for use as immunotherapeutic agents |
| 05/12/2009 | US7531630 Interferon-alpha polypeptides and conjugates |
| 05/12/2009 | US7531604 Phospholipid derivative containing a polyoxyalkylene group comprising two or more kinds of alkylene oxides, as well as a surfactant, solubilizer, dispersing agent; for cosmetics and lipid membrane structures; drug delivery of antitumor agents |
| 05/12/2009 | US7531562 Compositions and methods for protecting cells during cancer chemotherapy and radiotherapy |
| 05/12/2009 | US7531499 Spermine to facilitate absorption of cilostazol, rebamipide, cyclosporin and nifedipine |
| 05/12/2009 | US7531324 Interferon-alpha polypeptides and conjugates |
| 05/12/2009 | US7531191 Stimuli-responsive systems for controlled drug delivery |
| 05/12/2009 | US7531183 Biologically active hemagglutinin from type A Clostridium botulinum and methods of use |
| 05/12/2009 | US7531178 Immunoadhesin comprising a glycoprotein VI domain |
| 05/12/2009 | US7531164 Preventing bacterial or viral infectivity and composition containing infection preventing additive |
| 05/12/2009 | US7531162 Transcobalamin receptor binding conjugates useful for treating abnormal cellular proliferation |
| 05/12/2009 | US7530940 Methods of enhancing radiation effects with metal nanoparticles |
| 05/12/2009 | CA2611659A1 Method for enhancing delivery and uniformity of concentration of dietary ingredients |
| 05/12/2009 | CA2548078C Pharmaceutical formulations of camptothecins and process for making same |
| 05/12/2009 | CA2518102C Powdery preparation for nasal administration |
| 05/12/2009 | CA2478237C Use of adapalene for the treatment of dermatological disorders |
| 05/12/2009 | CA2416869C Vaccines |
| 05/12/2009 | CA2384301C Sustained-release drug formulations for implantation |
| 05/12/2009 | CA2377301C Controlled release and taste masking oral pharmaceutical compositions |
| 05/12/2009 | CA2377299C Mesalazine controlled release oral pharmaceutical compositions |
| 05/12/2009 | CA2356080C Improved formulation for transportation of corticosteroid through pores of a barrier |
| 05/12/2009 | CA2348842C Muco-adhesive polymers, use thereof and method for producing the same |
| 05/12/2009 | CA2335353C Compositions comprising phenylaminothiophenacetic acid derivatives for the treatment of acute or adult respiratory distress syndrome (ards) and infant respiratory distress syndrome (irds) |
| 05/12/2009 | CA2284079C Immunotoxins and methods of inducing immune tolerance |
| 05/12/2009 | CA2136492C Pharmaceutical composition containing diclofenac and 2-hydroxypropyl-.beta.-cyclodextrin |
| 05/09/2009 | CA2611540A1 Sugar chain-containing albumin, production method thereof and use thereof |
| 05/07/2009 | WO2009059309A2 Furin-cleavable peptide linkers for drug-ligand conjugates |
| 05/07/2009 | WO2009058815A2 Lipoxin a4 protection for retinal cells |
| 05/07/2009 | WO2009058585A2 Non-aqueous water-miscible materials as vehicles for drug delivery |
| 05/07/2009 | WO2009058399A1 A new class of therapeutics that enhance small molecule diffusion |
| 05/07/2009 | WO2009058387A2 Oligomer-nitroimidazole anti-infective conjugates |
| 05/07/2009 | WO2009058147A1 Loadable polymeric particles for therapeutic use in erectile dysfunction |
| 05/07/2009 | WO2009058135A1 Loadable polymeric microparticles for therapeutic use in alopecia and methods of preparing and using the same |
| 05/07/2009 | WO2009057812A1 Organic-inorganic hybrid nano particle composed of nucleic acid conjugate having polyethylene glycol bound thereto and calcium phosphate |
| 05/07/2009 | WO2009057787A1 Silica nanocapsule |
| 05/07/2009 | WO2009057768A1 Anti-fungal agent and anti-bacterial agent |
| 05/07/2009 | WO2009057763A1 Novel adjuvant |
| 05/07/2009 | WO2009057672A1 Method for stabilization of iodophor-containing solid preparation |
| 05/07/2009 | WO2009057569A1 Film-coated preparation |
| 05/07/2009 | WO2009057537A1 Pharmaceutical composition containing human mesenchymal stem cell |
| 05/07/2009 | WO2009057456A1 Gel sheet and cosmetic preparation in sheet form using the same |
| 05/07/2009 | WO2009057000A2 Skin cooling composition |
| 05/07/2009 | WO2009056826A1 Diagnostic and therapeutic methods and compositions for cardiovascular disease |
| 05/07/2009 | WO2009056547A1 Vancomycin and teicoplanin anhydrous formulations for topical use |
| 05/07/2009 | WO2009056322A2 Foam stabilizer for a sterilization composition |
| 05/07/2009 | WO2009056280A1 Antibodies which bind selectively to hair of animals and an antibody based drug delivery system for animals |
| 05/07/2009 | WO2009056114A2 Use of polyethylene glycol powders, and compositions containing the same |
| 05/07/2009 | WO2009055925A1 Enhanced nsaid formulations |
| 05/07/2009 | WO2009055923A1 Ingestible film composition |
| 05/07/2009 | WO2009055907A1 Apoptin induces inhibition of bcr-abl kinase in cml cells |
| 05/07/2009 | WO2009055860A1 Transdermal delivery system |
| 05/07/2009 | WO2009055859A1 Transdermal delivery system for hormones and steroids |
| 05/07/2009 | WO2009032266A3 Dispersions of microparticles and microgels in hydrogels for drug delivery |
| 05/07/2009 | WO2009031819A3 Composition for prevention or treatment of bone metabolism disorder comprising d-pinitol as an active ingredient |
| 05/07/2009 | WO2009025812A3 Apparatus to treat and prevent atrial tachyarrhythmias |
| 05/07/2009 | WO2009023742A9 Spore displaying antigens |
| 05/07/2009 | WO2009020645A3 Matriptase protein and uses thereof |
| 05/07/2009 | WO2008134013A3 Pharmaceutical excipient complex |
| 05/07/2009 | WO2008073856A3 Delivery of nanoparticles and/or agents to cells |
| 05/07/2009 | WO2008046541A3 Film-forming gel composition for wound or skin care |
| 05/07/2009 | WO2008039052A8 Process for stabilizing famotidine |
| 05/07/2009 | WO2007059171A3 Electrostatically controlled hydrogels |
| 05/07/2009 | WO2007041245A3 Biomarkers for multiple sclerosis and methods of use thereof |
| 05/07/2009 | US20090118380 Process for the preparation of water-in-oil and oil-in-water nanoemulsions |